PHEAST THERAPEUTICS Trademark

Trademark Overview

On Friday, March 4, 2022, a trademark application was filed for PHEAST THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PHEAST THERAPEUTICS trademark a serial number of 97295190. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, May 19, 2025. This trademark is owned by Pheast Therapeutics, Inc.. The PHEAST THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cancer

General Information

Serial Number97295190
Word MarkPHEAST THERAPEUTICS
Filing DateFriday, March 4, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, May 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of cancer
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePheast Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063
Party NamePheast Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94304

Trademark Events

Event DateEvent Description
Tuesday, March 8, 2022NEW APPLICATION ENTERED
Tuesday, March 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 15, 2022ASSIGNED TO EXAMINER
Friday, December 16, 2022NON-FINAL ACTION WRITTEN
Friday, December 16, 2022NON-FINAL ACTION E-MAILED
Friday, December 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 13, 2023SOU EXTENSION 1 FILED
Wednesday, December 13, 2023SOU EXTENSION 1 GRANTED
Friday, December 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 23, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 23, 2024SOU EXTENSION 2 FILED
Tuesday, November 26, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, November 26, 2024SOU EXTENSION 3 FILED
Wednesday, November 27, 2024SOU EXTENSION 3 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 19, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 23, 2024SOU EXTENSION 2 GRANTED
Friday, May 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 20, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 5, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 19, 2025SOU EXTENSION 4 FILED
Tuesday, May 20, 2025SOU EXTENSION 4 GRANTED
Thursday, June 5, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

therapeutics pheast cancer treatment preparations pharmaceutical